A Phase I trial of 90Y-anti-carcinoembryonic antigen chimeric T84.66 radioimmunotherapy with 5-fluorouracil in patients with metastatic colorectal cancer. [electronic resource]
Producer: 20040727Description: 5842-52 p. digitalISSN:- 1078-0432
- Antibodies, Monoclonal -- therapeutic use
- Antimetabolites, Antineoplastic -- therapeutic use
- Carcinoembryonic Antigen -- immunology
- Colorectal Neoplasms -- metabolism
- Combined Modality Therapy
- Feasibility Studies
- Fluorouracil -- therapeutic use
- Humans
- Maximum Tolerated Dose
- Radioimmunotherapy
- Recombinant Fusion Proteins -- therapeutic use
- Yttrium Radioisotopes -- therapeutic use
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Research Support, U.S. Gov't, P.H.S.; Review
There are no comments on this title.
Log in to your account to post a comment.